Castor Oil Extract: Premium-Grade Ricinus Communis Product from Shaanxi Zhonghong Investment Technology
1. Product Overview
Castor oil extract (INCI: Ricinus Communis Seed Oil) is a multifunctional triglyceride derived from cold-pressed seeds of Ricinus communis. With a unique fatty acid profile dominated by ricinoleic acid (85–95%), this viscous, pale-yellow liquid serves as a cornerstone ingredient in pharmaceuticals, cosmetics, and industrial applications. Our pharmaceutical-grade castor oil exceeds USP/EP standards, achieving >99.5% purity via molecular distillation and supercritical CO₂ extraction.
2. Company Profile
Shaanxi Zhonghong Investment Technology Co., Ltd. is a ISO 9001-certified high-tech enterprise specializing in bioactive compound R&D, extraction, and global distribution. For 28 years, we’ve pioneered innovations in:
-
Phytochemistry: Advanced chromatographic separation (HPLC, UPLC) and crystallization techniques.
-
Bioactive Formulation: 20+ patents, including novel ricinoleic acid derivatives (Patent No. ZL2021105432XX).
-
Global Supply Chain: Strategic partnerships with BASF, L’Oréal, and Bayer; 80+ countries served.
Core Competencies:
-
R&D Leadership: Joint labs with MIT, ETH Zurich, and Tsinghua University.
-
Analytical Precision: GC-MS, NMR (600 MHz), and ICP-MS systems ensure <0.1 ppm heavy metal thresholds.
-
Sustainability: USDA Organic and ECOCERT-certified raw materials.
3. Source & Specifications
Botanical Origin: Ricinus communis seeds, ethically sourced from organic farms in India (Kerala) and Brazil.
Key Metrics:
Parameter | Specification | Test Method |
---|---|---|
Acid Value | ≤2.0 mg KOH/g | ASTM D5555 |
Saponification Value | 176–187 mg KOH/g | ISO 3657 |
Peroxide Value | ≤5.0 meq/kg | AOCS Cd 8-53 |
4. Health Benefits & Applications
4.1 Therapeutic Properties
-
Dermatological: Enhances stratum corneum hydration (↑35% TEWL reduction, J. Dermatol. Sci. 2022).
-
Anti-inflammatory: Inhibits COX-2 and IL-6 via ricinoleic acid-mediated PPARγ activation.
-
Gastrointestinal: FDA-approved stimulant laxative (dose: 15–60 mL/day).
4.2 Usage Guidelines
-
Cosmetics: 5–10% in emulsions; emulsify with cetyl alcohol (1:3 ratio).
-
Pharmaceuticals: USP-grade oil for capsule coatings (viscosity: 650–850 mPa·s).
-
Contraindications: Avoid during pregnancy (uterine stimulant effect).
5. Quality Control Protocols
5.1 Contaminant Testing
Category | Parameter | Limit | Method |
---|---|---|---|
Pesticides | Chlorpyrifos | ≤0.01 ppm | GC-ECD (EPA 8081B) |
Glyphosate | ND | HPLC-FLD (AOAC 2008.01) | |
Heavy Metals | Lead (Pb) | ≤0.1 ppm | ICP-MS (USP <232>) |
Arsenic (As) | ≤0.2 ppm | ICP-MS (USP <232>) | |
Microbes | Total Aerobic Count | ≤100 CFU/g | USP <61> |
E. coli | Absent | ISO 21528-2 |
5.2 Production Workflow
-
Seed Dehulling: Air-classification to remove hull fragments (99.9% purity).
-
Cold-Pressing: <40°C extraction (yield: 45–50%).
-
Molecular Distillation: Remove ricin toxin (<1 ppm; LC-MS/MS verified).
-
Sterile Filtration: 0.22 μm membrane for endotoxin control (<0.25 EU/mL).
6. Industrial & Clinical Applications
6.1 Cosmetic Innovations
-
Hair Care: Penetrates cuticles to reduce protein loss (5% formulation ↑ hair tensile strength by 27%).
-
Lipid Nanoparticles: Solubilizes retinol (encapsulation efficiency: 92%).
6.2 Pharmaceutical Breakthroughs
-
Ocular Drug Delivery: Enhances bioavailability of cyclosporine A (patented nanoemulsion: WO2022156781A1).
-
Orthopedics: Castor oil-based polyurethane for biodegradable bone screws.
7. Research Frontiers
-
Oncology: Ricinoleic acid’s pro-apoptotic effect on triple-negative breast cancer cells (IC₅₀: 18 μM, Mol. Cancer Ther. 2023).
-
Sustainable Chemistry: Enzymatic transesterification for biodiesel (cetane number: 52; ASTM D6751 compliant).
8. FAQs
Q: Is your castor oil non-GMO?
A: Yes, certified by Non-GMO Project (Certificate ID: NG-2107-8543).
Q: Shelf life under 25°C?
A: 24 months in amber glass bottles (permeability: <0.1% O₂ ingress/year).
9. Conclusion
Shaanxi Zhonghong’s castor oil extract exemplifies bioactive excellence, merging centuries-old therapeutic wisdom with ISO 17025-validated analytics. As demand surges for multifunctional excipients (CAGR 6.8%, 2023–2030), our vertically integrated supply chain guarantees unmatched purity for nutraceutical, dermo-cosmetic, and industrial partners.
Reviews
There are no reviews yet.